6147 TWO Week ended 14 Aug 2026

Weekly Investor Report

Chipbond Technology Corporation · Technology · Semiconductor Equipment & Materials

Open interactive chart View report data
Latest close 157.5 TWD
7.5% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 11.0% above the Trend Line and sits at 41.5% of its 52-week range. The latest completed week returned 7.5%, after a -11.8% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.

Setup score 41 out of 100
Latest Close 157.5 TWD 14 Aug 2026
1W Return 7.5% latest completed week
4W Return -11.8% short-term follow-through
12W Return -26.0% quarterly tape
Trend Breadth 44.2% 23 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • The trend backdrop is active with a 22-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.
  • Recent volatility is running well above the one-year baseline.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 7.5% Latest completed week; four-week move -11.8%. Indicator stack 69/0 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 50/100 0 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 11.0% above the Trend Line and sits at 41.5% of its 52-week range. The latest completed week returned 7.5%, after a -11.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug 14 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6712-week average 0.92

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.67Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -11.8% over four weeks, -26.0% over 12 weeks, and 200.9% over one year. The current trend has remained active for 22 consecutive weeks.

Performance by holding period

1W7.5%
4W-11.8%
12W-26.0%
26W201.4%
52W200.9%
Active trend streak22 weeks
Active weeks in one year23
Trend breadth44.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.91Latest activity-pressure read.
Pressure change-5204.0%Four-week change in activity pressure.
Leadership20.91Latest relative-leadership reading.
RS change-59.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 0 relevant articles.

0 positive · 0 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-49.1%Distance below the 52-week high.
13-week volatility16.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher17 of 268 weeks finished lower.
Best week+41.8%Week of 29 May.
Worst week-17.7%Week of 17 Jul.
Latest week+7.5%Week of 14 Aug.

Shape of recent returns

Strong gains15
Modest gains2
Flat weeks1
Modest losses1
Sharp losses7
Recent vol16.6%13-week weekly-return volatility.
Base vol11.0%52-week weekly-return volatility.
Up/down split30/21Count of positive and negative weeks in the 52-week window.
Average skew9.0% / -6.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape49/100

Trend, activity pressure, participation, and risk combine to a 49/100 tape read.

 Indicator analysis77/100

Latest 12-week confirmation: trend 12/12, activity pressure 7/12, relative leadership 12/12.

Activity pressure 0.67; No reversal markers Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 0 relevant articles.

 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
14 Aug 2026157.5 TWD7.5%141.9 TWD75.65 TWD-0.9120.91134.8MOn
7 Aug 2026146.5 TWD12.7%138.5 TWD75.02 TWD-0.8117.49135.0MOn
31 Jul 2026130.0 TWD-17.7%135.4 TWD74.48 TWD-0.577.67202.2MOn
24 Jul 2026158.0 TWD-11.5%132.8 TWD74.02 TWD-0.3029.83116.0MOn
17 Jul 2026178.5 TWD-17.7%129.2 TWD73.38 TWD-0.0251.41138.6MOn
10 Jul 2026217.0 TWD0.7%125.0 TWD72.60 TWD0.2675.40133.7MOn
3 Jul 2026215.5 TWD-0.5%119.5 TWD71.56 TWD0.4571.75159.5MOn
26 Jun 2026216.5 TWD-14.1%114.1 TWD70.54 TWD0.8384.03156.9MOn
19 Jun 2026252.0 TWD13.9%108.6 TWD69.52 TWD1.25109.05105.0MOn
12 Jun 2026221.2 TWD-17.0%102.0 TWD68.27 TWD1.6097.21220.7MOn
5 Jun 2026266.7 TWD-11.6%96.50 TWD67.20 TWD1.90137.19319.6MOn
29 May 2026301.7 TWD41.8%89.57 TWD65.84 TWD1.97177.03312.2MOn
22 May 2026212.8 TWD5.1%81.42 TWD64.25 TWD1.95113.54396.1MOn
15 May 2026202.5 TWD3.5%76.21 TWD63.22 TWD1.87112.54243.0MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context